Novo Nordisk does not expect a shortage of its Wegovy weight-loss drug in Denmark despite an earlier warning by the Danish Medicines Agency of strained supply of two...

Tirzepatide was more effective than basal insulins in reducing A1c and postprandial glucose levels in a post hoc analysis.

Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the main ingredient in its popular weight-loss...

Prenatal exposure to extreme food deprivation led to a more than twofold increased likelihood of developing type 2 diabetes in adulthood.

The Tandem Control-IQ+ algorithm was recently cleared for use in T2D.

Echocardiography is independently associated with survival time and readmission rates in patients with type 2 diabetes.

Healthcare providers should adopt preventive measures for both asthma and type 2 diabetes in patients diagnosed with either condition, suggested a meta-analysis of 17 million individuals.

Med record data shows improvements in anxiety and depression in people taking the drugs for either diabetes or obesity.

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are increasingly viewed as adjuncts to insulin.

Novo Nordisk on Monday revealed data from a second late-stage trial of its obesity drug candidate CagriSema, knocking shares and stoking worries that rival Eli Lilly may be...

Following a medically supervised energy-restricted diet 2 days a week could improve glycemic control in patients with overweight or mild obesity and type 2 diabetes.

Using the same protocols for DKA in type 1 diabetes and DKA associated with SGLT2i use in type 2 diabetes could result in inappropriate insulin infusion dosing.

Diabetes, prediabetes, and hyperglycemia were linked to accelerated brain aging, but physical activity and abstention from smoking and heavy drinking may mitigate much of this effect.

French drugmaker Sanofi said on Wednesday uninsured diabetes patients in the United States will pay no more than $35 for 30-day supply of insulin, in the wake of heightened public scrutiny over soaring prices of the life-saving drug.

The new name and endorsement at the World Diabetes Congress are seen as long overdue recognition that will spur more research.

Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss...

The research examined users of weekly injections of tirzepatide, which is the active ingredient in Eli Lilly and Co.'s Zepbound.

Early morning hyperglycemia is sometimes called the "dawn phenomenon." Left untreated, it can drive poorer outcomes. How can it be detected and managed?

Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with diabetes transitioning from pediatric to adult endocrine care.

Gender prevalence is equal in young children, but trajectory appears to diverge around puberty.